IRIS
FERRAU', Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.835
NA - Nord America 5.620
AS - Asia 3.170
SA - Sud America 984
Continente sconosciuto - Info sul continente non disponibili 326
AF - Africa 87
OC - Oceania 3
AN - Antartide 1
Totale 16.026
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.474
RU - Federazione Russa 3.341
SG - Singapore 1.287
CN - Cina 939
BR - Brasile 831
IE - Irlanda 582
SE - Svezia 494
IT - Italia 435
HK - Hong Kong 324
DE - Germania 212
VN - Vietnam 207
PL - Polonia 174
FR - Francia 172
GB - Regno Unito 161
IN - India 87
FI - Finlandia 80
BD - Bangladesh 72
CA - Canada 56
AR - Argentina 48
MX - Messico 48
UA - Ucraina 39
TR - Turchia 36
ZA - Sudafrica 30
ID - Indonesia 28
BE - Belgio 27
CO - Colombia 24
JP - Giappone 24
EC - Ecuador 22
IQ - Iraq 22
UZ - Uzbekistan 21
NL - Olanda 19
PK - Pakistan 19
AT - Austria 18
MA - Marocco 18
VE - Venezuela 17
ES - Italia 15
PE - Perù 14
CZ - Repubblica Ceca 13
LT - Lituania 11
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
KE - Kenya 10
CR - Costa Rica 9
MY - Malesia 9
PH - Filippine 9
JO - Giordania 8
KG - Kirghizistan 8
AL - Albania 7
TN - Tunisia 7
IL - Israele 6
NP - Nepal 6
PY - Paraguay 6
UY - Uruguay 6
CI - Costa d'Avorio 5
GT - Guatemala 5
JM - Giamaica 5
OM - Oman 5
PA - Panama 5
AZ - Azerbaigian 4
BO - Bolivia 4
CH - Svizzera 4
DZ - Algeria 4
HN - Honduras 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
KH - Cambogia 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
NI - Nicaragua 3
PT - Portogallo 3
AM - Armenia 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
KZ - Kazakistan 2
LB - Libano 2
LC - Santa Lucia 2
LK - Sri Lanka 2
NO - Norvegia 2
SR - Suriname 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
EG - Egitto 1
HU - Ungheria 1
Totale 15.688
Salva come PNG Salva come JPEG
Città #
Moscow 923
Ashburn 818
Singapore 682
Dublin 581
Chandler 482
Dallas 469
San Jose 349
Beijing 340
Hong Kong 321
Nyköping 300
The Dalles 171
Warsaw 163
Council Bluffs 159
Messina 153
Los Angeles 134
Jacksonville 125
Munich 110
Princeton 101
Medford 93
Lauterbourg 92
New York 89
Ann Arbor 74
Dearborn 73
Des Moines 70
Cambridge 64
São Paulo 61
Ho Chi Minh City 57
Lancaster 55
Santa Clara 48
Hanoi 40
Shenyang 40
Buffalo 39
Atlanta 38
Redondo Beach 38
Brooklyn 37
Orem 36
Jinan 34
Tianjin 34
Frankfurt am Main 31
Guangzhou 29
Boardman 28
Wilmington 28
Brussels 26
Hyderabad 26
Seattle 26
Houston 25
London 25
Rio de Janeiro 25
Helsinki 24
Milan 24
Turku 24
Belo Horizonte 23
Denver 22
Nanjing 22
Catania 21
Curitiba 20
Tashkent 20
Montreal 19
Tokyo 19
Johannesburg 17
San Mateo 17
Chicago 16
Jakarta 15
Mexico City 15
Toronto 15
Vienna 15
Chennai 14
Dong Ket 14
Pune 14
Stockholm 14
Zhengzhou 14
Brasília 13
Nanchang 13
Rome 13
Ankara 12
Bremen 12
Düsseldorf 12
Hangzhou 12
Poplar 12
Shenzhen 12
Campinas 11
Manchester 11
Nuremberg 11
Porto Alegre 11
San Francisco 11
Bogotá 10
Haikou 10
Hillsboro 10
Ningbo 10
Phoenix 10
Shanghai 10
Taizhou 10
Woodbridge 10
Baghdad 9
Boston 9
Columbus 9
Da Nang 9
Goiânia 9
Lima 9
Nairobi 9
Totale 8.489
Salva come PNG Salva come JPEG
Nome #
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 314
Effects of cyberknife radiotherapy treatment of pituitary adenomas 296
Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study 292
Aggressive pituitary adenomas: the dark side of the moon 277
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 252
Biochemical control and clinical improvement is induced by long-term pasireotide administration in the majority of patients with Cushing[apos]s disease persistent after pituitary surgery 250
Aggiornamento sulla chirurgia ipofisaria per via endoscopica: indicazioni, vantaggi e limiti 242
Oral mucositis induced by treatment with soft gel formulation of levothyroxine 231
Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide 212
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 208
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 199
Diabetes secondary to acromegaly: Physiopathology, clinical features and effects of treatment 198
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 195
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 184
Global epidemiology of acromegaly: A systematic review and meta-analysis 184
Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden 182
An extremely rare association of TSH-secreting pituitary adenoma, metastatic neuroendocrine tumor and Cushing’s syndrome in a patient with MEN-1 gene mutation 181
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 181
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 179
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 179
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 178
Comment to ‘glucocorticoid resistance syndrome caused by a novel nr3c1 point mutation’ by al argan et al. 177
High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures 177
Increased prevalence of acromegaly in a highly polluted area. 175
PRIMARY EMPTY SELLA IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK, REGARDLESS THE OCCURRENCE OF PITUITARY DYSFUNCTION 173
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 170
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 169
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 167
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 167
Course of pregnancies in women with Cushing's disease treated by gamma-knife 165
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 164
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 158
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 158
Adrenal Cushing Syndrome: Diagnosis and Management in a 10-Year-Old Boy with Carney Complex 154
Multidisciplinary management of pituitary apoplexy 154
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 154
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 154
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 152
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 151
Adrenocorticotropin responsiveness to acute octreotide administration is not affected by mifepristone premedication in patients with Cushing's disease. 148
Effects of pasireotide treatment on cardio-metabolic risk in patients with Cushing's disease: an Italian, multicenter study 148
Osilodrostat (LCI699) per la cura della sindrome di Cushing 147
Thyroid nodules in growth hormone replaced patients. 146
Environmental Endocrinology and Endocrine Disruptors: Environmental Impact on the Hypothalamus–Pituitary Axis 144
Increased interleukin 22 circulating levels in patients with tumors involving the hypothalamic-pituitary region 144
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 144
Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells 144
An unusual case of idiopathic hyperprolactinemia 141
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 141
Absence of GNAS1 mutations in somatotropinomas from AIPmut positive patients: possible implications for phenotype. 140
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 140
Temozolomide-induced shrinkage of a pituitary carcinoma. 139
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 137
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 137
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy 133
Genetic and epigenetic modulation of AHR pathway in GH-secreting pituitary tumors and effects on acromegaly clinical phenotype 133
Health-related quality of life in patients with Cushing's syndrome 132
Long-term cardiometabolic outcome in patients with pituitary adenoma diagnosed in chilhood and adolescence 128
First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment. 127
Cabergoline-related impulse control disorder in an adolescent with a giant prolactinoma 127
Germline targeted next-generation sequencing in patients with adrenal incidentalomas 125
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. 122
The man with acromegaly who inspired the Shrek animated project. 122
Endocrinologia & Malattie del Metabolismo 122
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis 118
Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma 117
Pitfalls in the 2017 TNM Classification of Thyroid Carcinoma 117
Persistent severe visual field impairment is associated with obesity and tumour invasiveness, but not with pituitary dysfunction, in patients with craniopharyngioma 113
Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome 112
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 112
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas 111
Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors 107
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 106
Pregnancy after azathioprine therapy for ulcerative colitis in a woman with autoimmune premature ovarian failure and Addison's disease: HLA haplotype characterization. 106
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches 106
Are comorbidities of patients with adrenal incidentaloma tied to sex? 104
X-linked acrogigantism: a new condition of growth hormone excess. 104
Italian Guidelines for the Management of Prolactinomas 101
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies 101
Shrinkage of a pituitary metastasis of melanoma induced by pembrolizumab: a case report 100
Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project 99
What we have to know about corticosteroids use during Sars-Cov-2 infection 99
Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormone-secreting adrenal phaeochromocytoma: review of the literature and report of a case 97
How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild? 97
Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients 95
Metabolic comorbidities in Cushing's syndrome 95
GPR101 variants in acromegaly: results from a large series of patients. 94
The ubiquitin-specific peptidase 8 (USP8) gene is frequently mutated in adenomas causing Cushing's disease 94
Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms 94
The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing cushing's disease 90
Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion 89
Systemic comorbidities induce early vascular alterations in patients with active acromegaly. 87
Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas 87
Unique clinical picture in patients with X-linked acrogigantism 86
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 85
Landscape of familial isolated and young-onset pituitary adenomas: Prospective diagnosis in AIP mutation carriers 84
Approccio al paziente con tumore ipofisario aggressivo 83
Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor 83
Metabolic syndrome in cushing's syndrome patients 83
Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implications 83
Totale 14.503
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.138
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022655 0 69 12 30 18 10 27 23 10 95 119 242
2022/20231.710 162 177 77 132 112 157 36 91 683 14 43 26
2023/2024453 31 76 22 42 39 102 6 46 2 28 4 55
2024/20252.616 54 36 70 168 171 78 86 484 606 204 268 391
2025/20267.951 438 462 582 500 746 1.617 933 970 989 384 155 175
2026/20271.147 187 960 0 0 0 0 0 0 0 0 0 0
Totale 16.026